Morocco approves AstraZeneca/Oxford COVID-19 vaccine

“Morocco’s health ministry on Wednesday approved the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use, Health Minister Khalid Ait Taleb said. Morocco had announced it plans to launch a free vaccination campaign targeting 25 million people, or 80% of its population.”

More analysis from COVID-19 Africa Watch:

Interview with Megan McDonald: COVID-19, African Capital Markets, and What Lies Ahead
Interview: CBK Governor Dr. Patrick Njoroge on Kenya’s Priorities for Economic Resilience and Sustainability
Strive Masiyiwa: “How can I say science has delivered a miracle to people who are dying?”
A Global Warning System: Mobilizing Surveillance for Emerging Pathogens

COVID-19 Africa Watch tracks major developments and policy announcements from across the continent and also offers a curated selection of analysis on how the pandemic will impact African economies and development efforts. The site is a project of the Milken Institute’s Global Market Development Practice.

Explore Data & Charts Read the Latest News Track African Policy Decisions Subscribe

Morocco approves AstraZeneca/Oxford COVID-19 vaccine

More analysis from COVID-19 Africa Watch:

Share:

Explore

Engage

Get Updates

You might also like

More analysis from COVID-19 Africa Watch:

Share:

Explore

Engage

Get Updates